Renal Unit, Santa Maria Della Misericordia Hospital, Piazzale Menghini 1, 06132, Perugia, PG, Italy.
Department of Clinical and Experimental Medicine, Institute of Geriatrics and Gerontology, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy.
J Nephrol. 2018 Feb;31(1):71-77. doi: 10.1007/s40620-017-0413-y. Epub 2017 May 31.
The cardiovascular risk associated with an increase in serum creatinine below the acute kidney injury (AKI) threshold, during hospitalization, has not been studied in depth. We assessed patients' features and outcomes associated with these changes.
Retrospective cohort study of 12,493 consecutive patients admitted to hospital throughout 12 months. We investigated the patients who had a small creatinine increase (SISCr) between 1.2 and <1.5 times the admission value, and tested the association of creatinine changes with the prevalence of cardiovascular disease (CVD). In a follow-up study, we assessed the all-cause mortality and its relationship with SISCr.
Among patients with two or more creatinine measurements, 14.9% showed a SISCr. Older age, female gender and higher estimated glomerular filtration rate (eGFR) at admission were characteristics of these patients. The prevalence of CVD was 14.6% in patients with SISCr vs. 10.7% in those with stable creatinine (p < 0.001). SISCr was detected in 36, 26.6 and 18.9% of chronic heart failure (CHF), chronic ischemic heart disease (CIHD) and acute myocardial infarction (AMI) patients, respectively. The follow-up was 26.7 ± 10.6 months with 770 all-cause deaths. Serum creatinine increase above 20% was associated with a significant higher mortality compared to changes below 20%, adjusted hazard (HR) ratio 1.577 (p < 0.001). A higher risk was found associated with creatinine increases >1.5 times the baseline: HR 1.704 (p < 0.001).
In hospitalized patients, increases in serum creatinine below the AKI threshold are associated with CHF, CIHD and long-term mortality.
在住院期间,血清肌酐水平在急性肾损伤(AKI)阈值以下升高与心血管风险之间的关系尚未得到深入研究。我们评估了与这些变化相关的患者特征和结局。
这是一项在 12 个月内连续纳入 12493 例住院患者的回顾性队列研究。我们研究了血清肌酐升高幅度较小(SISCr)在 1.2 至<1.5 倍入院值之间的患者,并检验了肌酐变化与心血管疾病(CVD)患病率之间的相关性。在一项随访研究中,我们评估了全因死亡率及其与 SISCr 的关系。
在有两次或更多次肌酐测量值的患者中,14.9%的患者出现 SISCr。年龄较大、女性和入院时估算肾小球滤过率(eGFR)较高是这些患者的特征。与肌酐稳定的患者(10.7%)相比,SISCr 患者的 CVD 患病率为 14.6%(p<0.001)。在慢性心力衰竭(CHF)、慢性缺血性心脏病(CIHD)和急性心肌梗死(AMI)患者中,分别有 36%、26.6%和 18.9%的患者出现 SISCr。随访时间为 26.7±10.6 个月,共有 770 例患者发生全因死亡。与肌酐变化<20%的患者相比,肌酐升高超过 20%与死亡率显著升高相关,调整后的危险比(HR)比值为 1.577(p<0.001)。与基线相比,肌酐升高>1.5 倍的患者风险更高:HR 为 1.704(p<0.001)。
在住院患者中,血清肌酐水平在 AKI 阈值以下的升高与 CHF、CIHD 和长期死亡率相关。